Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satyavan Sharma is active.

Publication


Featured researches published by Satyavan Sharma.


Catheterization and Cardiovascular Interventions | 2006

Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: Preliminary experience with 18-month follow up

Robin Pinto; Bharat V. Dalvi; Satyavan Sharma

Background: This study reports our experience in the nonsurgical closure of perimembranous ventricular septal defects in children and adolescents with the Amplatzer asymmetric ventricular septal defect occluder and the outcome of an 18‐month follow up. Methods and Results: Twenty patients (median age:10 years; median weight:32 kg) with perimembranous ventricular septal defect were selected for transcatheter closure with the Amplatzer device. The prosthesis diameter chosen was 1–2 mm larger than the largest measured diameter of the defect on transesophageal echo (TEE). All patients were put on oral aspirin (5 mg/kg/day in children and 150 mg/day in adults) five days prior to and for six months after closure. Follow‐up evaluation at 48 hr and 1, 6, 12 and 18 months included clinical examination, electrocardiogram, and a transthoracic echocardiogram. The mean defect diameter on color flow mapping on TEE was 7.1 ± 2.3 mm. The device diameter ranged from 6–14 mm (median = 8 mm). One patient developed an anaphylactic reaction to contrast. The procedure was successful in 17 out of 19 patients where it was attempted (89.4%). In two patients with associated significant aortic valve prolapse and mild aortic regurgitation the device could not be successfully deployed. A trivial residual shunt observed during postdeployment left ventricular angiogram in 7 of 17 patients (41.2%) completely disappeared at one month follow‐up. Three patients had right bundle branch block (2 complete and 1 incomplete) whereas one developed junctional escape rhythm with a right bundle branch block morphology. One patient had clinically silent thromboembolism to the left vertebral artery and another patient had hemolysis which resolved spontaneously within 48 hr. Follow‐up at 13.5 ± 5.3 months (range 1–18 months) revealed no residual shunt. The left ventricular internal dimension in diastole decreased significantly from 45 ± 6 mm to 40 ± 6 mm (P < 0.01) at the time of the last follow up. The baseline tricuspid regurgitation (n = 4) and aortic regurgitation (n = 3) remained unchanged during the follow up period. None of the patients developed left ventricular outflow tract obstruction or new aortic or tricuspid regurgitation. There were no other device related complications such as device migration, systemic thromboembolism, infective endocarditis, pericardial effusion or delayed conduction disturbances. Conclusions: In carefully selected children and young adults, the Amplatzer asymmetric ventricular septal defect occluder is a promising device for transcatheter closure of perimembranous ventricular septal defect with encouraging results on short term follow up.


International Journal of Cardiology | 1991

Coarctation of aorta with unusual association of diverticulum of the left ventricle and double orifice mitral valve

Satyavan Sharma; Yunus S. Loya; Bipin V. Daxini

We describe a case of coarctation of aorta with two unusual associated anomalies, namely, a diverticulum of the left ventricle and double orifice of the mitral valve. Echocardiography and colour flow mapping precisely diagnosed the bridging tongue of leaflet tissue responsible for the double orifice of the mitral valve. Balloon angioplasty for coarctation produced dramatic benefits which are sustained at follow-up. The other two lesions caused no haemodynamic abnormality.


PLOS ONE | 2013

Association between gender, process of care measures, and outcomes in ACS in India: results from the detection and management of coronary heart disease (DEMAT) registry.

Neha J. Pagidipati; Mark D. Huffman; Panniyammakal Jeemon; Rajeev Gupta; Prakash Chand Negi; Thannikot M. Jaison; Satyavan Sharma; Nakul Sinha; P.P. Mohanan; B. G. Muralidhara; Sasidharan Bijulal; S. Sivasankaran; Puri Vk; Jacob Jose; K. Srinath Reddy; Dorairaj Prabhakaran

Background Studies from high-income countries have shown that women receive less aggressive diagnostics and treatment than men in acute coronary syndromes (ACS), though their short-term mortality does not appear to differ from men. Data on gender differences in ACS presentation, management, and outcomes are sparse in India. Methods and Results The Detection and Management of Coronary Heart Disease (DEMAT) Registry collected data from 1,565 suspected ACS patients (334 women; 1,231 men) from ten tertiary care centers throughout India between 2007–2008. We evaluated gender differences in presentation, in-hospital and discharge management, and 30-day death and major adverse cardiovascular event (MACE; death, re-hospitalization, and cardiac arrest) rates. Women were less likely to present with STEMI than men (38% vs. 55%, p<0.001). Overall inpatient diagnostics and treatment patterns were similar between men and women after adjustment for potential confounders. Optimal discharge management with aspirin, clopidogrel, beta-blockers, and statin therapy was lower for women than men, (58% vs. 65%, p = 0.03), but these differences were attenuated after adjustment (OR = 0.86 (0.62, 1.19)). Neither the outcome of 30-day mortality (OR = 1.40 (0.62, 3.16)) nor MACE (OR = 1.00 (0.67, 1.48)) differed significantly between men and women after adjustment. Conclusions ACS in-hospital management, discharge management, and 30-day outcomes did not significantly differ between genders in the DEMAT registry, though consistently higher treatment rates and lower event rates in men compared to women were seen. These findings underscore the importance of further investigation of gender differences in cardiovascular care in India.


American Heart Journal | 1997

Percutaneous double-valve balloon valvotomy for multivalve stenosis: Immediate results and intermediate-term follow-up

Satyavan Sharma; Yunus S. Loya; Dhruman M. Desai; Robin J. Pinto

Ten patients each with combined mitral and tricuspid stenosis (group 1) and with combined mitral and aortic stenosis (group 2) underwent double-valve balloon valvotomy as a single staged procedure. The aortic valve was dilated by the Mansfield balloon technique, whereas the mitral and tricuspid valves were dilated with either the Mansfield or Inoue balloon. The mitral valve area increased from 0.78 +/- 0.21 cm2 to 2.05 +/- 0.56 cm2 (p < 0.0005) in group 1 and from 0.75 +/- 0.20 cm2 to 2.1 +/- 0.59 cm2 (p < 0.05) in group 2. The tricuspid valve area increased from 1.11 +/- 0.41 cm2 to 2.52 +/- 0.69 cm2 (p < 0.0005). In group 2, the transaortic gradient decreased from 93.56 +/- 17.7 mm Hg to 28.56 +/- 7.8 mm Hg (p < 0.0005) and the valve area increased from 0.37 +/- 0.05 cm2 to 1.03 +/- 0.25 cm2 (p < 0.005). The excellent symptomatic and hemodynamic results were sustained at 30.3 +/- 9.8 months of follow-up in group 1 and at 23.5 +/- 9.1 months in group 2. Double-valve balloon valvotomy is feasible and safe and provides excellent immediate and intermediate-term follow-up results in selected patients with multivalve disease. A longer follow-up in a larger number of cases is needed to define further the role of this therapy.


Catheterization and Cardiovascular Interventions | 2011

Percutaneous transluminal renal stenting for transplant renal artery stenosis

Satyavan Sharma; Anil Potdar; Amit Kulkarni

Objectives: Renal transplantation is a well‐accepted therapeutic option for patients with end stage renal disease. Renal artery stenosis occurring in a transplanted kidney is a potentially serious condition and adversely affects graft survival and prognosis. The objective of this study is to document the immediate and intermediate term clinical results of renal stenting in this rare subset of renal artery stenosis. Background: There is limited data about the effectiveness of renal stenting in transplant renal artery stenosis. Methods: Eight patients, aged between 22 and 51 (42.5 ± 9.25) years, were referred to our tertiary care interventional cardiology services for renal intervention. The diagnosis of transplant renal artery stenosis was based on clinical presentation (uncontrolled hypertension (n = 4, 50%), worsening renal function (n = 3, 37.5%) or flash pulmonary oedema (n = 1, 12.5%)] and Doppler ultrasound. Results: All patients had live donor renal transplant using end to end anastomosis 2 to 11 (6.25 ± 3.24) months prior to intervention. Angiography revealed discrete stenosis at the anastomotic site. Intrarenal stenting performed from femoral access using 6 F accessories produced excellent angiographic results. There were no access site or procedure related complications. The intervention produced excellent immediate and intermediate term clinical results. In three patients, there was stabilization of renal function during 62 ± 9.16 months of follow‐up with decrease in serum creatinine by 38.86 ± 6.62 %; P = 0.0476. In four patients with refractory hypertension, excellent blood pressure control was achieved with a reduction in mean blood pressure by 25.95 ± 5.48 mm Hg (from 122.4 ± 5.7 to 96.45 ± 2.45 mm Hg; P = 0.0002) during 65.25 ± 23.79 months follow‐up. There was decrease in antihypertensive drug requirement from 3.75 ± 0.5 to 1.75 ± 0.5. During follow‐up, Doppler ultrasound documented a high peak systolic velocity in one asymptomatic patient with well controlled blood pressure and preserved renal function. Sustained benefits of percutaneous revascularization were supported by normal Doppler parameters in the remaining patients. Conclusions: Percutaneous renal stenting provides excellent angiographic and clinical results sustained at intermediate term follow‐up in patients with symptomatic transplant renal artery stenosis.


International Journal of Cardiology | 1994

Balloon dilatation of supravalvular aortic stenosis: a report of two cases

Robin J. Pinto; Yunus S. Loya; Ajit R. Bhagwat; Satyavan Sharma

Balloon dilatation was performed in two cases of supravalvular aortic stenosis with variable results. There was remarkable reduction in gradient in the patient with membranous obstruction and the benefits are sustained at 18 months follow-up. The patient with hour-glass obstruction had only a partial success with reappearance of obstruction within 1 week. Balloon dilatation may emerge as a viable treatment modality for membranous obstructions. However, a large study is needed to establish the place of this procedure.


International Journal of Cardiology | 1991

Anatomically corrected malposition : a rare case with bilateral absence of a complete subarterial muscular infundibulum

Yunus S. Loya; Ajit G. Desai; Satyavan Sharma

A unique case of anatomically corrected malposition of great arteries with a bilateral absence of a complete subarterial muscular infundibulum is presented. The other unusual feature of the case was absence of any complex associations and interestingly an intact ventricular septum. The presenting lesion was valvar pulmonary stenosis and balloon valvotomy could not be achieved because of abnormal relationship of the great vessels.


American Heart Journal | 1989

Echo-Doppler diagnosis of aortocaval fistula following blunt trauma to abdomen

Bipin V. Daxini; Ajit G. Desai; Satyavan Sharma

We are reporting this case of rare traumatic disease presenting with local, peripheral, and systemic manifestations that could be diagnosed noninvasively by echo-Doppler studies


International Journal of Cardiology | 1994

Transient myocardial dysfunction in a patient with subarachnoid haemorrhage

Robin J. Pinto; Venkat Goyal; Satyavan Sharma; S.N. Bhagwati

We report a patient of subarachnoid haemorrhage who presented with severe left ventricular dysfunction and marked electrocardiographic changes indistinguishable from acute myocardial infarction. Coronary arteriography showed normal anatomy and the ventricular regional wall motion abnormalities recovered spontaneously after 3 weeks. The implications of this association are discussed.


International Journal of Cardiology | 1990

Severe pulmonary hypertension in rheumatoid arthritis

Satyavan Sharma; Akshay Vaccharajani; Jyotsna V. Mandke

We report a patient with seropositive rheumatoid arthritis who had clinical and haemodynamic findings of severe pulmonary arterial hypertension. Histopathology proved this to be plexogenic rather than thromboembolic. We report the case to highlight this rare association.

Collaboration


Dive into the Satyavan Sharma's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bharat Dalvi

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Gupta Vp

University of Rajasthan

View shared research outputs
Top Co-Authors

Avatar

Nakul Sinha

Sanjay Gandhi Post Graduate Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Bharat Dalvi

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge